Michael James Enterprises, Inc. (OTCQB: MJTV) is pleased to report that MJTV has replaced Scott Weiner with Raj Pamnani, joining Gina Morreale and the Chairman of the Board, James M. Farinella. Mr. Pamnani has amassed a very impressive business track record bringing a wealth of relationships including, but not limited to, world renowned scientists and medical experts.

Mr. Pamnani has wealth of experience in the capital markets and focused on corporate finance, mergers and acquisitions, investment banking, and structuring bridge and mezzanine financings in the healthcare and information technology sectors. He served in corporate finance in New York at companies like Josephthal & Co. as Senior Vice-President and Merrill Lynch as Vice-President, where Mr. Pamnani managed over $70 million and has experience in negotiating and structuring private equity transactions.

Mr. Pamnani was instrumental in bringing several biotechnology companies public in the late 1980s and early 1990s, including Medarex, Zonagen, Texas Biotechnology, Ariad Pharmaceuticals, and SciClone Pharmaceuticals. He also has considerable business development experience. He has numerous international real estate and food related holdings, and served as a consultant to Citibank (Private Bank) in Singapore. Mr. Pamnani has a powerful international network of investors, entrepreneurs and others.

James Farinella, CEO of Michael James Enterprises, stated, "MJTV is truly blessed to have Raj join the board and bring his wealth of experience and talent. MJTV will now be adding a new product to the mix making the company a true Biotech."